Putting the financial interests aside, which is difficult considering the current pps, I can't put aside whether TPIV has and is continuing to develop what could be monumental in the treatment of cancer as well as infectious diseases. If TPIV could only enhance vaccines to prevent or minimize the threat of pandemic diseases that continue to threaten the world, it would be a travesty to delay or stop it's development. Now, in real time, people are dying and suffering from various cancers that TPIV products might prevent.
Just sayin, this is not your normal penny stock. The implications of its success are far reaching and will effect corporations with billions of dollars at stake if TPIV proves successful, just how far would they go to protect those assets? How far will Glynn go to ensure its success?
Is the science viable, that is the ultimate question and the answers are being developed in various trials with positive results.
Will all the products prove viable, or some of them or none at all?
But the bottom line is this science can't be stopped or delayed for lack of financing, the benefits are almost too incredible to even consider that from occurring.
News 
Market Data 
Discover 
